Service description
PreveCol® is a non-invasive screening test designed to identify the possible presence of colorectal cancer or pre-cancerous lesions (advanced adenomas) from a blood sample.
By means of this service, through a blood sample, the analysis of a series of biomarkers will be carried out, which will allow you to have a results report, with a positive or negative result on the possible presence or absence of colorectal cancer and/or precancerous lesions at the time of the test.
PreveCol® is intended for medium-risk individuals, of either sex, aged between 50 and 75 years (inclusive), who represent the population profile for which it has been clinically validated.